In this study, novel phosphatidylcholines containing ibuprofen or naproxen moieties were synthesized in good yields and high purities. Under the given synthesis conditions, the attached drug moieties racemized, which resulted in the formation of phospholipid diastereomers. The comperative studies of the cytotoxicity of ibuprofen, naproxen and their phosphatidylcholine derivatives against human promyelocytic leukemia HL-60, human colon carcinoma Caco-2, and porcine epithelial intestinal IPEC-J2 cells were carried out. The results of these studies indicated that phospholipids with NSAIDs at both sn-1 and sn-2 positions (15 and 16) were more toxic than ibuprofen or naproxen themselves, whereas 2-lysophosphatidylcholines (7 and 8) were less toxic against all tested cell lines. Phospholipids with NSAIDs at sn-1 and palmitic acid at sn-2 (9 and 10) were also less toxic against Caco-2 and normal cells (IPEC-J2).
Scientific RepoRTS | (2019) 9:220 | DOI:10.1038/s41598-018-36571-1 carried out on animal and human cells indicated that the mixture of NSAIDs and phosphatidylcholine exhibits stronger activity at identical concentrations and lower GI toxicity than NSAIDs alone [19] [20] [21] [22] . Moreover, phospholipids with linked drugs mediate the transport of compounds and increase their bioavailability 23 . Our studies showed that compounds with anticancer activity linked covalently with phosphatidylcholine in the place of natural fatty acids lose their toxicity toward normal cells 24, 25 .
In this paper, we report the synthesis of phosphatidylcholines containing ibuprofen (1) or naproxen (2) at sn-1 and/or sn-2 positions. Phosphatidylcholines with ibuprofen have previously been reported 26 but herein we applied a different, shorter synthetic pathway. Additionally, the cytotoxicity of the newly synthesized phospholipid derivatives against human promyelocytic leukemia HL-60 cells, human colon carcinoma Caco-2 cells, and porcine epithelial intestinal IPEC-J2 cells was studied.
Results and Discussion
Chemistry. Phosphatidylcholines containing ibuprofen (1) or naproxen (2) moieties at the sn-1 position (7) (8) (9) (10) were synthesized according to Fig. 2 . In the first steps, the corresponding chlorides 3 and 4, and stannylene acetal (6) were obtained. Acyl chlorides resulted from the reaction of acids 1 and 2 with oxalyl chloride in the presence of catalytic amounts of anhydrous DMF. Then, according to known procedures 24, 27, 28 , the reaction of stannylene acetal (6) and acyl chloride (3 or 4) gave the corresponding 2-lysophosphatidylcholine (7 or 8) in good yields (68 and 70%, respectively). In the next step, lysophosphatidylcholines 7 and 8 were esterified with palmitic acid using the Steglich conditions to give phosphatidylcholines 9 and 10, respectively.
The structures of lysophosphatidylcholines 7 and 8 were confirmed by NMR spectroscopy, since in the 1 H and 13 C NMR spectra of the two compounds, all hydrogen and carbon signals from the ibuprofen and naproxen moieties, respectively, were observed. Characteristic signals from the isobutyl group of compound 7 were observed at 0.85 and 0.86 ppm (d, J = 6.7 Hz) for the methyl groups and at 2.41 ppm (d, J = 7.2 Hz) for the methylene group. Moreover, the isobutyl methine proton was observed as a multiplet at δ = 1.81, CH 3 -3′ was detected as a doublet (J = 7.2 Hz) at 1.46 ppm, and the H-2′ methine proton was identified as a quartet (J = 7.2 Hz) at 3.72 ppm. Additionally, in the 1 H NMR spectrum of lysophosphatidylcholine 8 a characteristic singlet of the methoxy group at δ = 3.88 was visible, and the H-2′ and H-2 methine protons overlapped and gave multiplets in the range of 3.89-3.93 ppm (Supplementary Information).
The introduction of palmitic acid into the sn-2 position was confirmed by the appearance of signals from fatty acid residue in the 1 H NMR spectra of phosphatidylcholines 9 and 10. Triplets from terminal methyl groups at δ = 0.84 (J = 7.1 Hz) for 9 and at δ = 0.85 (J = 7.0 Hz) for 10 were observed. Additionally, the structures of 9 and 10 were confirmed by the shift in the methine proton H-2 signals from δ = 3.92 (7) to δ = 5.19 (9) and from δ = 3.91 (8) to δ = 5.19 (10), respectively. Moreover, phosphatidylcholines 9 and 10 were obtained as mixtures of diastereomers, which was a result of the enolization of the carboester group with contribution of H-2′ from the ibuprofen (1) and naproxen (2) . IBU and NAP are shortcuts of ibuprofen and naproxen moieties used in the following schemes. or naproxen moiety under mildly alkaline conditions 29 . However, in acidic solutions, NSAIDs are reportedly highly stable and do not undergo racemization 30 . The presence of two diastereomers of phosphocholine 9 was confirmed by the two quartets (J = 7.2 Hz) of H-2′ observed at 3.66 and 3.69 ppm and the two doublets (J = 7.2 Hz) of CH 3 -3′ at 1.43 and 1.44 ppm in the 1 H NMR spectrum. Double signals were also observed for CH 2 -1 and CH 2 -3, and in the 13 C NMR spectrum: C-1, C-1′, C-2′, C-3′, C-1″′, C-2″′, and C-3″′. The composition of the phosphatidylcholine isomers mixture (9) was determined by integrating one of the CH 2 -1 protons. Assuming that there was a higher content of phosphatidylcholine with S-ibuprofen, which was the starting enantiomer in the synthesis, the quantitative composition was defined as 77% 2 R,2′S isomer and 23% 2 R,2′R isomer. Phosphatidylcholine (10) with a naproxen moiety at the sn-1 position and palmitoyl residue at the sn-2 position was also obtained as a mixture of diastereomers. However, a pronounced advantage of the 2 R,2′S isomer was observed in this case. The intensities of the 1 H NMR signals from the 2 R,2′R isomer was so low (below 5%) that the percentage composition of the mixture could not be accurately determined. The smaller degree of racemization of the S-naproxen can be explained by the electron-donating effect of the methoxy group on the enol formation process.
Phosphatidylcholines containing palmitoyl residue at the sn-1 position and ibuprofen (12) or naproxen (13) at the sn-2 position were synthesized as depicted in Fig. 3 . First, 2-lysophosphatidylcholine 11 was prepared according to a known procedure by reacting stannylene acetal (6) and palmitoyl chloride 31 . Then, 2-lysophosphatidylcholine 11 was esterified with ibuprofen (1) or naproxen (2) using the Steglich conditions. The structures of phosphatidylcholines 12 and 13 were confirmed by NMR spectroscopy. In the 1 H NMR spectrum of 12 all signals of the palmitoyl residue were visible. Signals from the isobutyl group were observed at 2.41 ppm (d, J = 7.2 Hz) for the methylene protons, at 1.81 ppm (multiplet) for the methine proton, and at 0.86 ppm (d, J = 6.7 Hz) for the methyl groups. The presence of a multiplet at 5.20 ppm for H-2 indicated the attachment of the ibuprofen molecule onto the sn-2 position. Also, in the range of 7.03-7.17 ppm multiplets of the ibuprofen aromatic protons were visible. In addition, the structure of phosphatidylcholine 13 was confirmed by the presence of the following signals: 1.53 ppm (d, J = 7.1 Hz) from CH 3 -3′, 3.88 ppm (singlet) from the methoxy group, 5.21 ppm (multiplet) from H-2 and multiplets in the range of 7.08-7.70 ppm from the aromatic protons (Supplementary Information).
Similar to compound 9, phosphatidylcholine 12, was obtained as a mixture of diastereomers with similar quantitative composition: 73% of the 2 R,2′S isomer and 27% of the 2 R,2′R isomer. The presence of two diastereomers of 12 was indicated by the doubled signals for C3′ (17.57 and 17.63 ppm), C-2″′ (33.25 and 33.52 ppm), and C-3″′ (24.14 and 24.77 ppm) in the 13 C NMR spectrum. Interestingly, the rest of the carbon atoms from phosphatidylcholine 12 were present in the 13 C NMR spectrum as single signals. In contrast to compound 12, phosphatidylcholine 13 containing naproxen at the sn-2 position was detected as one isomer (2 R,2′S).
Phosphatidylcholines containing ibuprofen or naproxen moieties at both sn-1 and sn-2 positions (15 and 16) were synthesized in a one-step synthesis from the highly pure sn-glycero-3-phosphocholine (GPC) and ibuprofen (1) or naproxen (2), respectively ( Fig. 4) . In order to increase the solubility of GPC, its complex with cadmium chloride (14) was prepared according to a previously published procedure 24 . In the synthesis of 15 and 16, the Steglich esterification of two free hydroxyl groups in the presence of a fourfold molar excess of ibuprofen (1) or naproxen (2) was applied. The use of mass spectrometry was highly significant in the determination of the structures of products 15 and 16, since it detected intensive signals with m/z 634.3510 for 15 and m/z 682.2760 for 16. Additionally, the structures of these compounds were confirmed by 1 H, 13 C, and 31 P NMR spectroscopy. In the 1 H NMR spectra of 15 and 16, multiplied signals of acid moieties, glycerol, and choline were observed, which suggested the presence of four diastereomers in the product mixtures. Due to the substitution of identical molecules at the sn-1 and sn-2 positions and the racemization of acids bonded to GPC, the interpretation of the spectral data was complicated and very difficult. The racemization caused a formation of four diastereomers for both 15 and 16, respectively ( Fig. 5 ). Unfortunately, the separation of the individual isomers by a chiral HPLC column was impossible.
When looking at the 1 H NMR spectrum of 15 in the range of 1.29-1.43 ppm, the overlapping doublets (J = 7.2 Hz) of CH 3 -3′ a-b could clearly be observed. Their differentiation was caused by the direct attachment of the methyl group to the chiral C-2′ a-b carbon atom of the ibuprofen moiety. Moreover, the methine protons of H-2′ a-b were detected as multiplets in the range of 3.43-3.69 ppm. The separation of signals was imperceptible due to the large distance from the ibuprofen isobutyl moiety to the stereogenic center. In addition, in the range of 0.84-0.88 ppm doublets (J = 6.6 Hz) from the isobutyl methyl groups were detected and at 3.11, 3.12, 3.15, and 3.16 ppm, four singlets from the choline methyl groups were detected. This indicated the formation of four diastereomers of compound 15. Two-dimensional HSQC spectroscopy was instrumental in elucidating the structure of 15. The measurements detected signals of the CH 2 -α (δ = 4.11 and 4.19) and CH 2 -β (δ = 3.49 and 3.55) protons, multiplets of the CH 2 -1 protons in the range of 3.98-4.42 ppm, and multiplets of the CH 2 -3 protons in the range of 3.84-3.96 ppm. Multiplets of the methine proton H-2 were detected at δ = 5.15 and 5.20 ppm. In the 13 C NMR spectrum of phosphatidylcholine 15, signals of C-3′ a-b and C-2′ a-b in the ranges of 17.44-17.87 and 44.24-44.58 ppm, respectively, were observed. Multiplied signals of the glycerophosphocholine carbon atoms were detected at 58.54 and 58.60 ppm (C-α, two d, J C-P = 5.1 Hz), as well as in the ranges of 62.29-63.11 ppm (C-1 and C-3) and 65.75-65.90 (C-β). Interestingly, a single doublet (J C-P = 8.0 Hz) from the chiral C-2 carbon atom appeared at 70.21 ppm. The carbon atoms from the aromatic ring did not show any differentiation with exception of C-1″ a-b , which was closest to the chiral C-2′ a-b carbon atom and gave 8 signals in the range of 136.78-136.97 ppm. The signal of the ester carbon atom C-1′ a-b was also multiplied eight times and appeared in the range of 173.86-174.36 ppm. In the 31 P NMR spectrum, only one signal from the phosphorus atom of 15 was visible at δ = -1.02.
In the synthesis of phosphatidylcholine 16, a racemization of naproxen was also expected. The 1 H NMR spectrum clearly indicated the formation of diastereomers and the multiplication of almost all signals. Signals of CH 3 -3′ a-b appeared as eight doublets (J = 7.2 Hz) in the range of 1.23-1.49 ppm, while H-2′ a-b were visible as overlapping quartets (J = 7.2 Hz) at 3.39-3.81 ppm. The signals of the methoxy group were observed at 3.86 and 3.87 ppm as two singlets. Hydrogen atoms from the glycerophosphocholine fragment were also distinctly differentiated. The CH 2 -1 groups of each diastereomer gave rise to two doublet of doublets (J = 12.0, 7.0 Hz) with signals at 3.98, 4.11, 4.15, and 4.16 ppm from one of the protons, and a doublet of doublets (J = 12.0, 3.0 Hz) with signals at 4.23, 4.33, 4.41, and 4.44 ppm from the second. The CH 2 -3 groups appeared as two multiplets in the range of 3.80-3.95 ppm. Moreover, at 2.90, 2.91, 3.01, and 3.03 ppm four singlets that were assigned to the choline methyl groups were detected. Particularly interesting was the chemical shift of the first two singlets, because these proton signals have never been observed at such a high field for phosphatidylcholines. The CH 2 -β methylene groups appeared on the spectrum as two multiplets at 3.08 and 3.36 ppm, and the CH 2 -α protons appeared as three multiplets in the range of 3.72-3.84 ppm and at 4.05 ppm. The shifts of the N(CH 3 ) 3 and CH 2 -β signals toward the higher field, as well as the differentiation of the CH 2 -α protons, may indicate the influence of the naproxen moiety from the sn-2 position on the hydrophilic choline part of the molecule. Modeling of the phosphatidylcholine 16 structure showed that this may be the result of the rotation around the C2-C3 bond and the existence of two distinctive rotamers: one with the phosphocholine moiety in syn conformation to the naproxen at the sn-2 position and the second one in the anti. In the first conformation, which was stabilized by the nucleophilic interaction of the -N + (CH 3 ) 3 group and naphthalene electrons, the choline moiety was located in the shielding cone of the magnetic field induced by the electrons of the naphthalene ring. In the second conformation, the electrons of the aromatic ring did not affect the chemical shifts of the hydrogen atoms of the choline moiety.
In the 13 Cytotoxicity of the phosphatidylcholines containing ibuprofen and naproxen moieties. Taking into consideration the idea of the future application of novel phosphatidylcholines containing ibuprofen or naproxen moieties as anti-inflammatory drugs with reduced gastrointestinal toxicity, it is necessary to analyze the cytotoxicity of these derivatives against the sensitive and normal cells. Then, the cytotoxicity of ibuprofen, naproxen, and their phospholipid derivatives was analyzed by a WST-1 cell proliferation assay. Our earlier studies indicated that among different cell lines, human promyelocytic leukemia HL-60 cells are the most sensitive to modified phosphatidylcholines 24, 25, 32 . Therefore, HL-60 cells, gastrointestinal origin -human colon cancer Caco-2 cells and normal porcine epithelial intestinal IPEC-J2 cells were used in these studies. Phosphatidylcholine derivatives were dissolved in dimethyl sulfoxide (DMSO) prior to examination. Unfortunately, due to the poor solubility of compound 13 in DMSO, its cytotoxicity was not tested. The solvent did not show cytotoxicity against analyzed cell lines.
In the case of human leukemic HL-60 cells, the experiments revealed that ibuprofen (1) was non-toxic up to concentration of 100 µM. In contrast to ibuprofen (1), 2-lysophosphatidylcholine 7 was non-toxic even at concentration 200 µM (Fig. 6a , Table 1 ). However, phosphatidylcholines 9, 12 and 15 showed higher cytotoxic activity already at concentration 100 µM. The results of cytotoxicity studies of derivatives of ibuprofen against human colon carcinoma Caco-2 cells indicated that compounds 7, 9 and 12 at 200 µM concentration were less toxic than ibuprofen itself (Fig. 6b, Table 1 ). Phosphatidylcholines containing ibuprofen moieties at both sn-1 and sn-2 positions (15) showed higher toxicity in comparison to 1. Analysis of results of cytotoxic activity against normal porcine IPEC-J2 cells showed that compounds 7 and 9 were less toxic than ibuprofen (1) (Fig. 6c , Table 1 ). Phosphatidylcholines with ibuprofen in sn-2 position (12) and with two residues of ibuprofen (15) were more cytotoxic.
Incubation of HL-60 cells revealed that naproxen (2) was non-toxic toward these cells up to concentration 100 µM. Among phosphatidylcholines containing naproxen, only compound 8 was significantly less cytotoxic (up to concentration of 200 µM) in comparison to free naproxen (Fig. 7a , Table 2 ). On the other hand, compound 16, and especially 10 were highly toxic for HL-60 cells. In the case of colon carcinoma Caco-2 cells naproxen (2) was less toxic in comparison to leukemic HL-60 cells. Interestingly, also in contrast to leukemic cells, compound 10 was non-toxic up to concentration of 200 µM against the colon carcinoma cells. These cells were only sensitive to compound 16 (Fig. 7b , Table 2 ). The activity of phosphatidylcholines 8, 10 and 16 have similar effect for both normal porcine IPEC-2 cells and colon carcinoma Caco-2 cells (Fig. 7b ,c, Table 2 ). Phosphatidylcholines 8 and 10 were less toxic than naproxen (2) towards these cell lines at concentration 200 µM.
The results of these studies showed that phosphatidylcholines containing NSAIDs at both sn-1 and sn-2 positions (15 and 16) were more toxic than ibuprofen or naproxen themselves. 2-Lysophosphatidylcholines (7 and 8)
were less toxic against all tested cell lines. Phospholipids with NSAIDs in sn-1 and palmitic acid in sn-2 (9 and 10) were also less toxic against Caco-2 and normal cells (IPEC-J2).
Conclusions
In this study, we synthesized eight phosphatidylcholines with ibuprofen or naproxen in their sn-1, sn-2 or sn-1 and sn-2 positions, and the cytotoxicity of the resulting compounds towards two cancer cells (HL-60 and Caco-2) and normal IPEC-J2 cells was evaluated. The results from the biological studies indicated that 2-lysophosphatidylcholines with NSAIDs at sn-1 position (7 and 8) and phosphatidylcholines with NSAIDs at sn-1 and palmitic acid residue at sn-2 (9 and 10) were less toxic against Caco-2 and normal cells (IPEC-J2). Compounds 7 and 8 were also less toxic than ibuprofen or naproxen against HL-60 cells. These results confirmed our earlier observations that phospholipid derivatives of active compounds are less cytotoxic than the compounds themselves. These data indicate also that phospholipids could be used as carriers of NSAIDs. However, further biological studies are necessary in order to confirm this proposal. The complexes of cadmium chloride and sn-glycero-3-phosphocholine (14, GPCxCdCl 2 ), and 1-palmitoyl-2 -hydroxy-sn-glycero-3-phosphocholine (11) were prepared according to previously reported procedures 31,33 . Syntheses. General procedure for the preparation of 2-lysophosphatidylcholines 7 and 8. S-Ibuprofen (1, 0.3 g, 1.46 mmol) or S-naproxen (2, 0.34 g, 1.46 mmol) was dissolved in anhydrous methylene chloride (5 mL), and catalytic amount (2 drops) of anhydrous DMF was added to the mixture. Excess of oxalyl chloride (3 equiv, 376 μL, 4.38 mmol) was added dropwise to the stirring solution. The reaction was carried out at room temperature for 2 h and the solvent and excess of oxalyl chloride were subsequently evaporated. The resulting chloride 3 or 4 was immediately used for the synthesis of 2-lysophosphatidylcholine 7 or 8.
Materials and Methods

Chemicals and Analysis Conditions. sn-Glycero-3-phosphocholine (GPC) was purchased from Bachem
GPC (0.25 g, 0.97 mmol) and DBTO (0.242 g, 0.97 mmol) were suspended in 15 mL of 2-propanol and refluxed for 2 h. The mixture was cooled to room temperature and TEA (0.203 mL, 1.46 mmol) and corresponding chloride 3 or 4 were then added to it. The mixture was stirred for 30 min. After completion of the reaction (checked by TLC) the solvent was evaporated under reduced pressure and the residue was purified by silica gel column chromatography using chloroform:methanol:water (65:25:2 → 65:25:4) to give the corresponding 2-lysophosphatidylcholine (7 or 8).
1-[2′S-(4″-Isobutylphenyl)]propanoyl-2-hydroxy-sn-glycero-3-phosphocholine (7): Colorless, waxy product; yield 68% (0.292 g). 1 General procedure for the preparation of phosphatidylcholines 9 and 10. Lysophosphatidylcholine 7 (0.089 g, 0.2 mmol) or 8 (0.094 g, 0.2 mmol) and DMAP (0.025 g, 0.2 mmol) were dissolved in dry methylene chloride (5 mL). The, a mixture of palmitic acid (2 equiv, 0.103 g, 0.4 mmol) and DCC (3 equiv, 0.124 g, 0.6 mmol) in the same solvent (5 mL) was added. The reaction was stirred for 72 h at room temperature. The suspension was filtered off and stirred with Dowex ® resin (50WX8 H + ) for 30 min. The resin was then filtered off and washed with a Folch mixture (15 mL). The solvent was evaporated and the crude product was purified by column chromatography on silica gel (CHCl 3 :CH 3 OH:H 2 O, 65:25:4) to give the corresponding phosphatidylcholines 9 or 10. The yields and the physical and spectroscopic data of the products are given below. Table 2 . IC 50 values ( ± SD) of naproxen (2) and phosphatidylcholines containing naproxen moieties (8, 10 and 16). na -not active in the range of concentrations tested (50-200 µM). a NAP -naproxen. b IC 50 -half-maximal inhibitory concentration.
